Cefazolin in Dextrose 20 mg/mL Recall: Particulate Matter
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx…
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Cefazolin in Dextrose 20 mg/mL recalled?
Presence of Particulate Matter
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Which lot codes, UPCs or models are affected?
Lot # LD175708, Exp Date: 14-Feb-2027.
- Agency record number
- D-0787-2026
- Product
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx…
- Recalling firm
- Baxter Healthcare Corporation
- Quantity
- 19,032 bags
- Distribution
- US Nationwide.
- Recall started
- July 24, 2026
- Report date
- August 19, 2026
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)